Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Pitini
Vincenzo
V
Arrigo
Carmela
C
Righi
Maria
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000134:cerebrospinal fluid; D058846:Antibodies, Monoclonal, Murine-Derived; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D003606:Dacarbazine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D000069283:Rituximab; D000077204:Temozolomide
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018906:Antineoplastic Agents, Alkylating; D000069283:Rituximab; D003606:Dacarbazine; D000077204:Temozolomide